(1) Laurell CB, Eriksson S. The electrophoretic alpha1-globulin pattern in serum alpha1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963; 15: 132-140.
(2) McElvaney NG, Stoller JK, Buist AS, et al. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest. 1997; 111: 394–403.
(3) Eden E, Mitchell D, Mehlman B, et al. Atopy, asthma, and emphysema in patients with severe alpha-1-antitrypysin deficiency. Am J Respir Crit Care Med. 1997; 156: 68-74.
(4) Siri D, Farah H, Hogarth DK. Distinguishing alpha1-antitrypsin deficiency from asthma. Ann Allergy Asthma Immunol. 2013; 111: 458–64.
(5) No authors listed. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997; 75: 397–415.
(6) Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. European Respiratory Journal 2017; 50: 1700610.
(7) Dawkins PA, Dawkins CL, Wood AM, et al. Rate of progression of lung function impairment in α1-antitrypsin deficiency. Eur Respir J. 2009; 33:1338–1344.
(8) Hiller AM, Piitulainen E, Jehpsson L, et al. Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2019; 14: 1075-1083.
(9) Coates AL, Wanger J, Cockcroft DW, Culver BH; Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen, Diamant Z, Gauvreau G, Hall GL, Hallstrand TS, Horvath I, de Jongh FHC, Joos G, Kaminsky DA, Laube BL, Leuppi JD, Sterk PJ. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017 May 1;49(5)
(10) Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, 2018. Available online at ginasthma.org.
(11) Jia CE, Zhang HP, Lv Y, et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis. J Allergy Clin Immunol. 2013; 131: 695-703.
(12) Ferrarotti I, Thun GA, et al. Serum levels and genotype distribution of α1-antitrypsin in the general population. Thorax. 2012;67:669-674.
(13) Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017; 50.
(14) Gorrini M, Ferrarotti I, et al. Validation of a Rapid, Simple Method to Measure 1-Antitrypsin in Human Dried Blood Spots. Clin Chem. 2006; 52: 899-901.
(15) Pellegrino R, Viegi G, Brusasco V, et al. Interpretativestrategies for lung function tests. Eur Respir J. 2005; 26: 948-968.
(16) Oostveen E, MacLeod D, Lorino H, et al.ERS Task Force on Respiratory Impedance Measurements: The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003; 22: 1026-1041.
(17) Hall WJ, Hyde RW et al. Pulmonary Abnormalities in Intermediate Alpha-1-Antitrypsin Deficiency. J Clin Invest 1976;58(5):1069-1077
(18) Thomson NC, Chaudhuri R, Livingsto E. Active cigarette smoking and asthma. Clin Exp Allergy. 2003; 33: 1471–1475.
(19) Vance JC, Hall WJ, Schwartz RH, et al. Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children. 1977; 60: 263-272.
(20) Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest. 2006; 129: 369-377.
(21) Lutfi MF. Acceptable alternatives for forced vital capacity in the spirometric diagnosis of bronchial asthma. Int J Appl Basic Med Res. 2011; 1: 20-23.
(22) Suárez Lorenzo I, Rodríguez de Castro F, et al. Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites. Clin Transl Allergy 8:44, 2018.
(23) Townley RG, Southard JG, Radford P, et al. Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990; 98: 594-599.
(24) Rosenfeld GB. α1-antitrypsin heterozygosity and spirometric function in chronic asthma. J Allergy Clin Immunol. 1976; 57: 218-219.
(25) Katz RM, Lieberman J, Siegel SC. Alpha-1-antitrypsin levels and prevalence of Pi variant phenotypes in asthmatic children. J Allergy Clin Immunol. 1976; 57: 41-45.
(26) Eden E, Strange C, Holladay B, et al. Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med. 2006; 100: 1384-1391.
(27) Miravitlles M, Vilà S, Torrella M, et al. Influence of deficient alpha1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med. 2002; 96: 186-192.